Living Safely With Covid
banner
covidsafenz.bsky.social
Living Safely With Covid
@covidsafenz.bsky.social
Covid Safe NZ #CovidIsNotOver

Layers of Protection: Vaccines + Masks + Ventilation + Filtration
Indoor Air Quality Standards
Masks in Healthcare and Aged Care

Aotearoa New Zealand Kikorangi

Pandemics | Typos
Reposted by Living Safely With Covid
Thank you for highlighting this again, Natalie. We know multiple outbreaks of zoonotic viruses are in the pipeline. Most seem to be airborne for obvious reasons. A piecemeal approach isn't working. Proper public health measures do.
November 19, 2025 at 9:35 AM
Reposted by Living Safely With Covid
#PublicHealth measures like ventilation and air filtration are a matter of urgency

"Chances that disease X will be an influenza virus are probably greater than for any other known pathogen group"

time.com/7324877/flu-...
As the Flu Surges in Asia, Could Getting Sick Year-Round Be the New Normal?
Here’s what medical experts say could be behind the recent rise of influenza cases in Japan, India, Singapore, Thailand, and more.
time.com
November 3, 2025 at 8:34 PM
Reposted by Living Safely With Covid
6/ The simulation showed that where the wind blew, the virus followed.

In the first few weeks of the virus’ spread, I found that farms downwind were 20x as likely to see outbreaks.
November 18, 2025 at 9:11 PM
Reposted by Living Safely With Covid
People think clean air is politics. No—clean air is breathing.
November 15, 2025 at 6:09 PM
Reposted by Living Safely With Covid
More work linking irregular iris pigmentation in gannets to prior HPAI infections: likelihood of NP antibody increased with iris pigment irregularity. Moderate correlations for H5 antibodies.
👉 www.biorxiv.org/content/10.1...
November 18, 2025 at 10:52 PM
Reposted by Living Safely With Covid
Mass General Brigham: 'Trial evaluates a vitamin B3 derivative in people with long COVID'

'The clinical trial tested whether raising levels of NAD⁺—a molecule that helps cells produce energy—through nicotinamide riboside (NR), a form of vitamin B3..'

medicalxpress.com/news/2025-11...
Trial evaluates a vitamin B3 derivative in people with long COVID
Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological issu...
medicalxpress.com
November 18, 2025 at 3:12 PM
Reposted by Living Safely With Covid
Repeated infections are causing long-term immune disruption — and the signs are already showing up across populations.

We break down the evidence, the context, and the urgent need for prevention in our latest piece.

Read the full article here:
whn.global/scientific/t...

#LongCOVID #COVID19 #COVID
November 18, 2025 at 6:18 PM
Serological Evidence of HPAI (#H5N1) in Invasive Wild Pigs in Western Canada

Legitimate concern that wild pigs could act as mixing vessels for bird + human flu strains
➡️ emergence of new more swine-adapted reassortants
➡️ swine strain could infect people and create a novel pandemic virus in humans
November 18, 2025 at 6:23 PM
Reposted by Living Safely With Covid
3/ When examining plasma from individuals who received the JN.1-adapted vaccine, we observe similar levels of antibody evasion for XFG and BA.3.2. This is consistent with earlier studies.
November 17, 2025 at 10:55 AM
Reposted by Living Safely With Covid
7/ In summary, BA.3.2 has firmly established itself and is unlikely to disappear soon. A JN.1-like trajectory is possible. However, no subvariant has yet emerged with mutations that provide a clear selective advantage.
November 17, 2025 at 10:55 AM
Reposted by Living Safely With Covid
The Antigen Evolution & Design lab will focus on using AI-enabled methods to uncover molecular interactions within antigen protein sequences and structures. This approach will be used for designing better, broader immunity vaccines.

More info will follow soon, stay tuned! 😁😁
November 15, 2025 at 6:42 AM
More countries need to invest in researching, preventing & treating Long COVID

“Karl Lauterbach: The CDU/CSU and SPD want to invest more money in research into post-infectious diseases like Long Covid. Former Health Minister Lauterbach says that Germany could thus become a global leader.”
Germany will invest in research on Long COVID and related conditions — great news!
Karl Lauterbach: Forschung gegen ME/CFS wird ausgeweitet: Union und SPD wollen mehr Geld in die Erforschung postinfektiöser Erkrankungen wie Long Covid stecken. Deutschland könne damit zum weltweiten Vorreiter werden, sagt Ex-Gesundheitsminister Lauterbach.
November 15, 2025 at 7:09 PM
The Washington State Department of Health has announced their presumptive H5 bird flu case announced yesterday has tested positive , not for #H5N1, but for HPAI #H5N5 - the first recorded case in humans.

bsky.app/profile/fla-...
November 14, 2025 at 9:48 PM
Reposted by Living Safely With Covid
NEW: Washington state reports human case of bird flu, patient hospitalized. Waiting for CDC confirmation
November 14, 2025 at 1:23 AM
Reposted by Living Safely With Covid
In human nasal and lung organoids, human H9N2 from 2024 (A/HK/2346/2024) replicated and 1999(A/HK/1073/1999) did not. mammalian-adaptive substitution PB2-D253N emerged de novo.
👉 www.tandfonline.com/doi/full/10....
November 11, 2025 at 5:06 AM
Reposted by Living Safely With Covid
NOTUS: MAHA’s Gone Viral. Can Science?

▶️ bit.ly/4qQQvUz

via @notus.com
by @margaretmanto.bsky.social
November 10, 2025 at 7:57 PM
Reposted by Living Safely With Covid
I want to spell this out in case the implications aren't clear:

This means all public tools/webapps of GISAID data (all the ones you've been used to seeing thru the pandemic, as far as we can tell) are prohibited.

The file allowed this. Cut that - cut off all tools the public & others were using.
On Oct 1, 2025, GISAID informed us that they had ended updates to the flat file of SARS-CoV-2 genomic sequences and associated metadata that we had used to update Nextstrain analyses since Feb 2020. GISAID's stated rationale was that their "resources are limited". 1/5
November 7, 2025 at 2:41 PM
Reposted by Living Safely With Covid
We are looking for teachers willing to test Jasper, a CO2 monitor in their classrooms. Jasper is a prototype and we would like to receive user feedback as soon as possible from several countries. If you are interested, please fill out the form: letsair.org/jasper
November 7, 2025 at 11:28 AM
Reposted by Living Safely With Covid
So we have four branches of BA.3.2 circulating now
two BA.3.2.1 related each other but distinct and two BA.3.2.2 related but distinct.
My take about this is that both lineages are enough tuned to not disappear , with BA.3.2.2 having the potential of expand further.
November 1, 2025 at 1:10 PM
Reposted by Living Safely With Covid
Your best bet is to email Pharmac to ask when LP.8.1 vaccine will be available

You can also check their website for updates

If you hear anything feel free to tag us so we can share it
www.pharmac.govt.nz/medicine-fun...
COVID-19 vaccines
Pharmac is responsible for the management of COVID-19 vaccines. This includes funding, procurement, and supply.
www.pharmac.govt.nz
October 30, 2025 at 11:08 PM
Reposted by Living Safely With Covid
Old 3M N95 masks stayed effective for up to 13 years (though straps may fail).
October 30, 2025 at 6:48 PM
Pfizer Comirnaty LP.8.1 vaccine approved 30 Oct by Medsafe NZ

Timing of rollout is up to Pharmac, which has noted feedback that people want earlier access to updated vaccines

Note: JN.1 approved 7 Nov 24, rolled out 20 Jan 25
Hope we don’t have to wait until 2026 for LP.8.1!
October 30, 2025 at 10:00 PM
🦠Heads up. BA.3.2 has arrived in NZ

BA.3.2 detected in Aotearoa New Zealand wastewater
3.2% for the week to 5 October

BA.3.2 is not shown in the fortnight to 19 Oct. However, variants with a national percentage of < 1% are not included so BA.3.2 is likely to still be circulating
October 30, 2025 at 4:06 AM
LP.8.1 mRNA vaccine:

💠 Markedly boosts neutralising antibody responses against
NB.1.8.1 and XFG

💠 Much lower neutralising antibodies against BA.3.2.2 infections
1️⃣ Georg Behrens, Markus Hoffmann & team examined antibody responses induced by the novel LP.8.1-adapted mRNA vaccine.
October 28, 2025 at 1:11 AM